NCT03327649View on ClinicalTrials.gov

Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

March 30, 2021

Study Completion Date

September 30, 2021

Conditions
Heart Failure With Normal Ejection Fraction
Interventions
DEVICE

low level transcutaneous vagus nerve stimulation

Stimulation of the auricular branch of the vagus nerve

Trial Locations (1)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT03327649 - Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter